Lewell X Q
Glaxo Group Research Ltd., Ware, Herts., United Kingdom.
Drug Des Discov. 1992;9(1):29-48.
From the known experimental data on adrenergic ligands and beta-2 receptor a model for the ligand binding sites was proposed and built. Agonist and antagonist have overlapping but different binding sites. The model correlates well with the structural information known from a series of adrenergic ligands.